Table 2.
Samples | Concentrations (μg/ml) | Average inhibition | Percent inhibition | LC50 (μg/ml) |
---|---|---|---|---|
Ph.Cr | 1000 | 21.66 ± 0.66 | 72.20 ± 2.2*** | 342.53 |
500 | 17.66 ± 0.33 | 58.86 ± 1.1*** | ||
250 | 13.00 ± 1.15 | 43.33 ± 3.8*** | ||
125 | 09.33 ± 0.88 | 31.10 ± 2.9*** | ||
62.5 | 09.33 ± 0.33 | 31.10 ± 1.1*** | ||
31.25 | 06.00 ± 0.57 | 20.00 ± 1.9*** | ||
Ph.Hex | 1000 | 17.00 ± 0.00 | 56.66 ± 0.0*** | 657.72 |
500 | 14.33 ± 0.88 | 47.76 ± 2.9*** | ||
250 | 11.33 ± 0.33 | 37.76 ± 1.1*** | ||
125 | 08.66 ± 0.88 | 28.86 ± 2.9*** | ||
62.5 | 07.00 ± 1.73 | 23.33 ± 5.7*** | ||
31.25 | 05.33 ± 1.45 | 17.76 ± 4.8*** | ||
Ph.Chf | 1000 | 25.66 ± 0.66 | 85.53 ± 2.2* | 73.81 |
500 | 21.33 ± 0.88 | 71.10 ± 2.9*** | ||
250 | 17.00 ± 0.57 | 56.66 ± 1.9*** | ||
125 | 16.66 ± 0.00 | 55.53 ± 0.0*** | ||
62.50 | 14.33 ± 0.88 | 47.76 ± 2.9*** | ||
31.25 | 14.33 ± 0.33 | 47.76 ± 1.1*** | ||
Ph.EtAc | 1000 | 24.00 ± 0.57 | 80.00 ± 1.9** | 217.19 |
500 | 19.33 ± 0.33 | 64.43 ± 1.1*** | ||
250 | 15.66 ± 0.33 | 52.20 ± 1.1*** | ||
125 | 13.00 ± 1.15 | 44.33 ± 3.8*** | ||
62.50 | 11.66 ± 0.66 | 38.66 ± 2.2*** | ||
31.25 | 10.00 ± 0.00 | 33.33 ± 0.0*** | ||
Ph.Bt | 1000 | 20.00 ± 0.57 | 66.66 ± 1.9*** | 439.83 |
500 | 16.00 ± 0.57 | 53.33 ± 1.9*** | ||
250 | 11.33 ± 0.88 | 37.76 ± 2.9*** | ||
125 | 10.00 ± 0.57 | 33.33 ± 1.9*** | ||
62.50 | 07.66 ± 0.33 | 25.53 ± 1.1*** | ||
31.25 | 06.00 ± 0.57 | 20.00 ± 1.9*** | ||
Ph.Aq | 1000 | 16.66 ± 0.66 | 55.53 ± 2.2*** | 881.12 |
500 | 11.00 ± 0.00 | 36.66 ± 0.0*** | ||
250 | 09.00 ± 1.15 | 30.00 ± 3.8*** | ||
1250 | 07.00 ± 1.73 | 23.33 ± 5.7*** | ||
62.5 | 06.33 ± 1.45 | 21.10 ± 4.8*** | ||
31.25 | 04.33 ± 0.88 | 14.43 ± 2.9*** | ||
Ph.Sp | 1000 | 27.00 ± 0.57 | 90.00 ± 1.9ns | 18.39 |
500 | 24.00 ± 0.00 | 80.00 ± 0.0ns | ||
250 | 22.33 ± 0.33 | 74.43 ± 1.1* | ||
125 | 21.00 ± 1.15 | 70.00 ± 3.8*** | ||
62.50 | 18.00 ± 0.57 | 60.00 ± 1.9*** | ||
31.25 | 17.33 ± 0.88 | 57.76 ± 2.9*** |
Vincristine sulfate was used as positive control having IC50 < 0.1 μg/ml. Values significantly different as compare to positive control,
P < 0.05,
P < 0.01,
:P < 0.001.
ns, Values not significantly different in comparison to standard drug.